Read + Share
Amedeo Smart
Independent Medical Education
Bulubas L, Goerigk S, Gomes JS, Brem AK, et al. Cognitive outcomes after tDCS in schizophrenia patients with prominent negative symptoms: Results from the placebo-controlled STARTS trial. Schizophr Res 2021;235:44-51.PMID: 34304146
Email
LinkedIn
Facebook
Twitter
Privacy Policy